Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

The introduction in 1998 of imatinib mesylate (IM) revolutionized management of patients with chronic myeloid leukemia (CML) and the second generation of tyrosine kinase inhibitors may prove superior to IM. Real-time quantitative polymerase chain reaction (RQ-PCR) provides an accurate measure of the...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Hughes, Timothy, Deininger, Michael, Hochhaus, Andreas, Branford, Susan, Radich, Jerald, Kaeda, Jaspal, Baccarani, Michele, Cortes, Jorge, Cross, Nicholas C. P., Druker, Brian J., Gabert, Jean, Grimwade, David, Hehlmann, Rüdiger, Kamel-Reid, Suzanne, Lipton, Jeffrey H., Longtine, Janina, Martinelli, Giovanni, Saglio, Giuseppe, Soverini, Simona, Stock, Wendy, Goldman, John M.
Formáid: Artigo
Teanga:Inglês
Foilsithe: The American Society of Hematology 2006
Ábhair:
Review in Translational Hematology
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895821/
https://ncbi.nlm.nih.gov/pubmed/16522812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-01-0092
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla